Double primary lung adenocarcinoma diagnosed by epidermal growth factor receptor mutation status.
10.12701/yujm.2017.34.2.270
- Author:
Oh Jung KWON
1
;
Min Hyeok LEE
;
Sung Ju KANG
;
Seul Gi KIM
;
In Beom JEONG
;
Ji Yun JEONG
;
Eun Jung CHA
;
Do Yeun CHO
;
Young Jin KIM
;
Ji Woong SON
Author Information
1. Department of Internal Medicine, Konyang University Hospital, Daejeon, Korea. sk1609@hanmail.net
- Publication Type:Case Report
- Keywords:
Adenocarcinoma;
Differential diagnosis;
Lung cancer;
DNA sequence analysis;
Mutations
- MeSH:
Adenocarcinoma*;
Biopsy;
Constriction;
Diagnosis, Differential;
Epidermal Growth Factor*;
Female;
Genetic Testing;
Humans;
Lung Neoplasms;
Lung*;
Middle Aged;
Radiography, Thoracic;
Receptor, Epidermal Growth Factor*;
Sequence Analysis, DNA;
Thorax
- From:Yeungnam University Journal of Medicine
2017;34(2):270-274
- CountryRepublic of Korea
- Language:English
-
Abstract:
A nodular density was detected on a chest radiograph taken from a 57-year-old Korean woman who was visiting a hospital for a routine check. Chest computed tomography revealed a 4.8 cm lobulated mass in the right lung and another focal nodular lesion in the left lung; biopsies of both lungs revealed adenocarcinoma. We conducted DNA sequencing and peptide nucleic acid clamping to investigate the potential double primary lung cancer. The results verified that the mass in the right lung had a mutation in the epidermal growth factor receptor, whereas the nodule in the left lung had a wild-type sequence, showing that these two were genetically different cancers from one another. Thus, we demonstrate that genetic testing is useful in determining double primary lung cancer, and we herein report on this case.
